Amplify Weight Loss Drug & Treatment ETF Rating $19.55 -1.29 (-6.19%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.78Holdings in THNR have an aggregate rating of Moderate Buy based on 184 analyst ratings issued in the past year covering 14 companies (70.0% of the portfolio).THNR Aggregate Price Target$19.580.17% UpsideHigh Prediction$19.58Average Prediction$19.58Low Prediction$19.58Holdings in THNR have an aggregate price target of $19.58 and a range of $19.58 to $19.58 covering 14 companies (70.0% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy8 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 14 THNR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.66%LLYEli Lilly and Company$737.56-6.5%4.9037 of 5 stars2.84$1,009.72 36.9%19Gap Down13.76%NVONovo Nordisk A/S$62.58-6.7%4.8037 of 5 stars2.80$145.25 132.1%105.05%WSTWest Pharmaceutical Services$203.00-7.7%4.4634 of 5 stars2.86$332.50 63.8%7Positive News5.01%TMOThermo Fisher Scientific$437.71-6.9%4.8508 of 5 stars2.82$653.23 49.2%22Positive News4.71%MRKMerck & Co., Inc.$81.48-5.7%5 of 5 stars2.65$117.12 43.7%23Analyst Revision4.68%AZNAstraZeneca$68.46-7.4%3.5716 of 5 stars3.10$89.75 31.1%10Positive NewsGap Down4.65%PFEPfizer$22.99-5.4%4.9684 of 5 stars2.63$31.92 38.9%164.63%AMGNAmgen$294.39-5.0%4.302 of 5 stars2.48$314.04 6.7%23Positive News4.49%TEVATeva Pharmaceutical Industries$13.83-6.9%2.2156 of 5 stars2.86$23.43 69.4%7Analyst UpgradeShort Interest ↑Analyst RevisionGap Down3.65%HIMSHims & Hers Health$25.93-7.4%3.7353 of 5 stars2.27$37.31 43.9%15Gap Down1.73%GPCRStructure Therapeutics$15.12-7.4%2.0119 of 5 stars3.00$81.29 437.6%8News CoverageGap Down1.50%VKTXViking Therapeutics$22.62-6.6%4.2951 of 5 stars3.00$95.18 320.8%12Gap Down0.28%OPKOPKO Health$1.55-1.3%4.127 of 5 stars3.00$2.75 77.4%3Insider TradeShort Interest ↑News Coverage0.22%ALTAltimmune$4.24-4.9%2.0935 of 5 stars2.89$20.83 391.4%9Analyst ForecastGap Down This page (NYSEARCA:THNR) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
